SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, Penny Traders Club, bz777, HighYieldStocks
Search This Board: 
Last Post: 4/30/2017 12:30:46 PM - Followers: 396 - Board type: Free - Posts Today: 1



Arrayit (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.


- Powerful Science for Life™



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARYC News: Current Report Filing (8-k) 12/05/2016 04:31:06 PM
ARYC News: Current Report Filing (8-k) 12/05/2016 03:16:26 PM
#43578  Sticky Note SKULL AND CROSSBONES FOR ARYC. lucky,mydog 04/15/17 01:08:12 PM
#43132  Sticky Note I am here at arrayit office . ANRK 04/10/17 01:52:45 PM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#41045  Sticky Note Here are the details and DD updates ChartAnalyst 02/08/17 10:32:34 AM
#45440 jrsh 04/30/17 12:30:46 PM
#45439   Barchart Opinions show traders what a variety of Ken1998 04/29/17 09:02:25 PM
#45438   That's why ARYC is under a penny per share. UndervaluedStocks 04/29/17 08:40:20 PM
#45437   Re: your statement "Financials are not late" MikeCr 04/29/17 08:38:36 PM
#45436   That's only people who believe Arrayit is a techmover 04/29/17 08:11:08 PM
#45435 lol. that's a big thumbs down. 93% FAKE. lucky,mydog 04/29/17 08:07:42 PM
#45434   I will be more than happy to buy UndervaluedStocks 04/29/17 08:06:05 PM
#45433   BASED SOLY ON ALEXA USERS: Alexa’s traffic estimates techmover 04/29/17 08:04:31 PM
#45432   that's complete and total nonsense. this scam has lucky,mydog 04/29/17 08:02:45 PM
#45431   Members use a tool bar for those rankings. techmover 04/29/17 07:59:48 PM
#45430   I understand your position on this and would ScreenerBoy 04/29/17 07:58:20 PM
#45429   I'm telling look up about Alexa and techmover 04/29/17 07:55:29 PM
#45427   You can say what you want. I have ScreenerBoy 04/29/17 07:53:13 PM
#45426   Alexa isn't to be trusted their ranking system techmover 04/29/17 07:49:33 PM
#45425   This is HUGE DD! Those of you who ScreenerBoy 04/29/17 07:45:26 PM
#45424   Financials are not late, they have until May UndervaluedStocks 04/29/17 07:24:32 PM
#45423   Only if the financials do get released, can sonofkatz 04/29/17 06:09:10 PM
#45422   Count me in!! glory2000 04/29/17 01:58:01 PM
#45421   Thank you! Labradorite 04/29/17 11:56:21 AM
#45420   I am sitting on the ARYC Bid every UndervaluedStocks 04/29/17 11:45:51 AM
#45419   ARYC Morningstar rating: singnificantly undervalued with current market Ken1998 04/29/17 11:21:05 AM
#45418   Labradorite - Arrayit's Transfer Agent MikeCr 04/29/17 11:08:56 AM
#45416   Hi UndervaluedStocks, can you give me a link Labradorite 04/29/17 11:05:37 AM
#45415   Hi Mike, can you give me a link Labradorite 04/29/17 11:04:38 AM
#45414   How about this: Let's say there is 2 UndervaluedStocks 04/29/17 10:52:22 AM
#45413   Are you saying that the Transfer Agent has MikeCr 04/29/17 10:52:05 AM
#45412   Mike, it really doesn't matter. Even though your UndervaluedStocks 04/29/17 10:47:34 AM
#45411   Call the Transfer agent. They'll tell you the facts. MikeCr 04/29/17 10:45:16 AM
#45410   Go visit the company UndervaluedStocks 04/29/17 10:41:41 AM
#45408   Show us the link to that fact. MikeCr 04/29/17 10:40:41 AM
#45407   Yes they do UndervaluedStocks 04/29/17 10:39:43 AM
#45406   Management does not own 300 M common shares. MikeCr 04/29/17 10:39:14 AM
#45405   .....Unless you're including the 300m owned by ARYC management UndervaluedStocks 04/29/17 10:38:22 AM
#45404   SS as of April 1, 2017. MikeCr 04/29/17 10:36:14 AM
#45403   750 float 1 b OS .... sales are UndervaluedStocks 04/29/17 10:08:11 AM
#45402   Undervalued. What's the current SS here? JEck017 04/29/17 10:06:46 AM
#45401   Yessir. I would expect May19, thank you UndervaluedStocks 04/29/17 12:16:57 AM
#45400   When arrayit was filing 1st quarter results they JOHCOOP 04/28/17 11:51:29 PM
#45399   Nice to see so many level headed people Labradorite 04/28/17 09:13:13 PM
#45398   I'm new here but I've been where you havnagoodtime 04/28/17 08:52:56 PM
#45397   Makes perfect sense. It lets investors get ready HotStockAlerts 04/28/17 08:02:39 PM
#45396   Good luck to both of you!!! And have Meq 04/28/17 07:20:05 PM
#45395   Yeah it does. Build up through the weekend. Lazio1900 04/28/17 05:27:54 PM
#45394   They won't be released today. Pencow 04/28/17 05:26:34 PM
#45393   If they do untangle that web, ARYC share UndervaluedStocks 04/28/17 05:12:37 PM
#45392   If fins today, anyone projection on time of day? Lazio1900 04/28/17 04:55:10 PM
#45391   Delsurfer - I agree 100% MikeCr 04/28/17 04:40:39 PM
#45390   Mike - we've been here a long time Delsurfer 04/28/17 04:36:56 PM
#45389   I agree and my comment was a "general havnagoodtime 04/28/17 04:23:00 PM
#45388   I one time, many years ago, also saw MikeCr 04/28/17 04:22:11 PM